My recommendation for Xylem Inc. (NYSE: XYL ) is a buy rating, as it offers pure-play exposure to the structural water scarcity, aging infrastructure, and PFAS treatment themes that drive durable, non-discretionary demand. Management’s 80/20 transformation is already delivering tangible margin gains, while the EvoquaI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental str ...